RecruitingNot ApplicableNCT06130215

Simple Meal Management Using Automated Insulin Delivery System

Evaluation on Glycemic Control Using Two Different Meal Announcement Plans in Adolescents With Type 1 Diabetes on Minimed 780G Hybrid Closed Loop System

Sponsor

Sidra Medicine

Enrollment

34 participants

Start Date

Nov 15, 2023

Study Type

INTERVENTIONAL

Conditions

Type 1 Diabetes

Summary

Carbohydrate counting is an essential component of diabetes management in both adults and children, and together with an intensive insulin plan and increased blood glucose monitoring was associated with lower HbA1c. Carbohydrate counting is perceived as one of the most burdensome tasks in T1D and is frequently done inconsistently and with poor accuracy A recent analysis confirms that MiniMed™ Advaced Hybrid closed loop (AHCL) system is designed for optimal performance with meal announcement. Nonetheless, when meals containing \< 80 grams of carbohydrates are consumed with announcement of meals at will, there is a slight reduction in the number of daily boluses with no decline in glycemic control, yet markedly less diabetes related distress and improved treatment satisfaction TIR of 78.1% in unannounced meals compared with 78.8% with announced meals .

Eligibility

Min Age: 12 YearsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study looks at how well an automated insulin pump system (called an advanced hybrid closed-loop system) can manage blood sugar around mealtimes for people with type 1 diabetes. The system automatically adjusts insulin based on glucose sensor readings. Researchers want to find a simpler way for people to handle meals without as much manual input. **You may be eligible if...** - You are 12 years or older - You have been diagnosed with type 1 diabetes for more than 1 year - You use more than 8 units of insulin per day - You have internet access at home to download data from the device - Your doctor believes you can safely start using the automated insulin system **You may NOT be eligible if...** - You are pregnant - You have untreated diabetic eye disease or other conditions that would prevent safe participation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSimple meal management

* Regular meal: Total Carbs per Day x 0.6 / 3 * Large meal: Total Carbs per Day x 0.6 / 3 x 1.5 * Small (Snack) meal: Total Carbs per Day x 0.6 / 3 x 1.5

OTHERPrecise meal management

precise carbohydrate counting for each meal

Locations(1)

Sidra Medicine

Doha, Qa, Qatar

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06130215

Related Trials

French Prospective Multicentric Study in Real World

NCT0703994224 locations

Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes

NCT061445541 location

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

NCT0678330928 locations

The Effect of Improved Glycemic Control on the Composition and Function of High-Density Lipoproteins (HDL) in Patients With Type 1 Diabetes

NCT075647521 location

Permissive Versus Strict Intrapartum Glucose Management in Type 1 Diabetes (PRISM-T1D)

NCT072937151 location